title: Engagement of the medical-technology sector with society.
abstract: The medical-technology sector must educate society in an unbiased rational way about the successes and benefits of biotechnology innovation.
authors.affiliation: Professor of Biomaterials and Director of International Affairs, Wake Forest Institute of Regenerative Medicine, Winston-Salem, NC 27191, USA. dfwillia@wakehealth.edu eedelman@mit.edu.
authors.forename: David
authors.identifier: 0000-0001-5173-3157
authors.initials: D
authors.lastname: Williams
authors.affiliation: MIT Cabot Professor of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dfwillia@wakehealth.edu eedelman@mit.edu.|Professor of Medicine, Harvard Medical School, Boston, MA 02139, USA.
authors.forename: Elazer R
authors.identifier: 0000-0002-7832-7156
authors.initials: ER
authors.lastname: Edelman
authors.affiliation: Professor at Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Milica
authors.identifier: 0000-0003-1249-4135
authors.initials: M
authors.lastname: Radisic
authors.affiliation: University Professor at University of Connecticut and CEO of Connecticut Institute for Clinical and Translational Science, Farmington, CT 06030, USA.
authors.forename: Cato
authors.identifier: 0000-0001-6765-3047
authors.initials: C
authors.lastname: Laurencin
authors.affiliation: Vice President of Research and Technology, Medtronic Inc., Minneapolis, MN 55432, USA.
authors.forename: Darrel
authors.initials: D
authors.lastname: Untereker
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000379:methods*; D003695:Delivery of Health Care; D006801:Humans; D014481:United States